切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (06) : 698 -700. doi: 10.3877/cma.j.issn.1674-3946.2025.06.027

综述

经肛门内镜微创手术治疗直肠肿瘤应用研究进展
蒲茜, 文曰(), 卢春燕, 赵锐   
  1. 610041 成都,四川大学华西医院普外科、胃肠外科病房
  • 收稿日期:2024-07-19 出版日期:2025-12-26
  • 通信作者: 文曰
  • 基金资助:
    成都市医学科研课题(2023063)

Advances in the application of transanal endoscopic microsurgery in the treatment of rectal tumors

Xi Pu, Yue Wen(), Chunyan Lu, Rui Zhao   

  1. Department of General Surgery, Division of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu Sichuan Province 610041, China
  • Received:2024-07-19 Published:2025-12-26
  • Corresponding author: Yue Wen
引用本文:

蒲茜, 文曰, 卢春燕, 赵锐. 经肛门内镜微创手术治疗直肠肿瘤应用研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 698-700.

Xi Pu, Yue Wen, Chunyan Lu, Rui Zhao. Advances in the application of transanal endoscopic microsurgery in the treatment of rectal tumors[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(06): 698-700.

经肛门内镜微创手术(TEM)是治疗直肠肿瘤常用术式,主要通过直肠镜的多功能手术操作系统实现整块切除,已广泛应用于直肠腺瘤等良性病变、早期直肠癌以及各种直肠罕见病。与经腹开放或腔镜手术相比,TEM式精准度更高、损伤和痛苦更小、恢复时间更短、功能保护更好。近年来,新辅助放化疗联合局部切除为进展期直肠癌综合治疗提供了新方向。但新辅助放化疗联合TEM的有效性仍存在争议。本研究就近年来TEM治疗直肠肿瘤的研究进展进行分析和总结,为今后临床治疗提供参考。

Transanal Endoscopic Microsurgery (TEM) is a commonly used surgical procedure for the treatment of rectal tumors. It primarily achieves en bloc resection through a multi-functional surgical operating system of rectoscopes and has been widely applied in surgeries for benign lesions such as rectal adenomas, early-stage rectal cancer, and various rare rectal diseases. Compared with open transabdominal surgery or laparoscopic surgery, TEM offers higher precision, less trauma and pain, shorter recovery time, and better functional preservation. In recent years, neoadjuvant chemoradiotherapy combined with local resection has provided a new direction for the comprehensive treatment of advanced rectal cancer. However, the effectiveness of neoadjuvant chemoradiotherapy combined with TEM remains controversial. This study analyzes and summarizes the research progress of TEM in the treatment of rectal tumors in recent years, aiming to provide a reference for future clinical treatment.

[1]
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin202171(3): 209-249.
[2]
Hossain MS, Karuniawati H, Jairoun AA, et al. Colorectal cancer:a review of carcinogenesis,global epidemiology,current challenges,risk factors,preventive and treatment strategies[J]. Cancers, 2022, 14(7): 1732.
[3]
O’Sullivan DE, Sutherland RL, Town S, et al. Risk factors for early-onset colorectal cancer:a systematic review and meta-analysis [J]. Clin Gastroenterol Hepatol, 2022, 20(6): 1229-1240.
[4]
许剑民, 常文举, 鉴谧. 达芬奇机器人直肠癌根治术的现状和发展[J/CD]. 中华普外科手术学杂志(电子版), 2020, 14(01): 9-12.
[5]
何瑜,唐宽平, 马晓颖. 5-钙黏蛋白、基质金属蛋白酶9在结直肠癌组织中的表达及临床意义[J]. 陕西医学杂志, 2021, 50(05): 618-621.
[6]
杨洋, 陆雄, 陈海伟, 等. 肛门内镜显微手术在腹腔镜直肠癌手术中应用效果研究[J]. 陕西医学杂志, 2018, 47(08): 987-989.
[7]
傅莫凡, 徐康, 尚伟, 等. 经肛门内镜微创手术治疗后病理分期pT1期高危和pT2期直肠癌追加同步放化疗效果观察[J]. 山东医药, 2022, 62(33): 61-63.
[8]
Buess G, Theiss R, Hutterer F, et al. Transanal endoscopic surgery of the rectum-testing a new method in animal experiments[J]. Leber Magen Darm, 1983, 13(2): 73-77.
[9]
李福广, 金鑫, 姚书鹏, 等. 经肛门内镜微创手术治疗直肠腺瘤的临床效果观察[J]. 中国医刊, 2021, 56(12): 1312-1315.
[10]
白雪杉, 林国乐, 薛晓强, 等. 以经肛门内镜微创手术为平台经肛全直肠系膜切除术治疗中低位直肠癌的临床疗效[J]. 中华消化外科杂志, 2021, 20(03): 339-345.
[11]
刘李, 杨烈, 杨柳, 等. 腹腔镜下改良Bacon’s直肠癌根治术对患者术后肛门功能与远期疗效观察[J/CD]. 中华普外科手术学杂志(电子版), 2020, 14(01): 46-49.
[12]
Heidary B, Phang TP, Raval MJ, et al. Transanal endoscopic microsurgery: a review [J]. Can J Surg, 2014, 57(2): 127-138.
[13]
Shi WK, Hou R, Li YH, et al. Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors [J]. BMC Surg, 2022, 22(1): 43.
[14]
Ammann Y, Warschkow R, Schmied B, et al. Is survival after transanal total mesorectal excision (taTME) worse than that after traditional total mesorectal excision? A retrospective propensity score-adjusted cohort study [J]. Int J Colorectal Dis, 2024, 39(1): 28.
[15]
Lin YC, Kuo YT, You JF, et al. Transanal total mesorectal excision (TaTME) versus laparoscopic total mesorectal excision for lower rectal cancer:a propensity score-matched analysis [J]. Cancers, 2022, 14(17): 4098.
[16]
Tirelli F, Lorenzon L, Biondi A, et al. Functional outcomes after transanal total mesorectal excision (TaTME): a random forest analysis to predict patients’ outcomes [J]. Tech Coloproctol, 2023, 27(11): 1037-1046.
[17]
Chernyshov SV, Shelygin YA, Mainovskaya OA, et al. Possibilities of transanal endoscopic microsurgery: the experience of 202 operations [J]. Vopr Onkol, 2015, 61(6): 998-1005.
[18]
Clancy C, Burke JP, Albert MR, et al. Transanal endoscopicmicrosurgery versus standard transanal excision for the removal of rectal neoplasms: systematic review and meta-analysis [J]. Dis Colon Rectum, 2015, 58(2): 254-261.
[19]
Hart A, Clifford K, Thompson-Fawcett M. Recurrence after transanal endoscopic microsurgery for benign and malignant rectal tumours:experience of a single New Zealand centre [J]. ANZ J Surg, 2024, 94(3): 412-417.
[20]
郑冠鹏, 胡旭晨, 刘天佑. 经肛门内镜微创手术治疗直肠肿瘤研究进展[J]. 中国普外基础与临床杂志, 2022, 29(06): 835-840.
[21]
Serra-Aracil X, Flores-Clotet R, Mora-López L, et al. Transanal endoscopic microsurgery in very large and ultra large rectal neoplasia [J]. Tech Coloproctol, 2019, 23(9): 869-876.
[22]
Zhang Y, Yu P, Wang P, et al. Analysis of the therapeutic effect of transanal endoscopic microsurgery on large rectal adenoma [J]. J Minim Access Surg, 2022, 18(4): 571-577.
[23]
Koreli A, Briassoulis G, Sideris M, et al. Transanal endoscopic microsurgery (TEMS)for rectal cancer: patient decision-making,postoperative experience and quality of life [J]. In Vivo, 2021, 35(2): 1235-1245.
[24]
Junginger T, Goenner U, Hitzler M, et al. Analysis of local recurrences after transanal endoscopic microsurgery for low risk rectal carcinoma [J]. Int J Colorectal Dis, 2017, 32(2): 265-271.
[25]
Morino M, Allaix ME, Caldart M, et al. Risk factors for recurrence after transanal endoscopic microsurgery for rectal malignant neoplasm [J]. Surg Endosc, 2011, 25(11): 3683-3690.
[26]
Xue X, Lin G. Transanal endoscopic microsurgery: exploring its indications and novel applications. A narrative review[J]. Wideochir Inne Tech Maloinwazyjne, 2022, 17(1): 95-103.
[27]
Keeping AC, Johnson PM, Kenyon CR, et al. Timing of recurrences of TEM resected rectal neoplasms is variable as per the surveillance practices of one tertiary care institution[J]. Sci Rep, 2021, 11(1): 6509.
[28]
Johnson GGRJ, Robertson RL, Vergis A, et al. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer [J]. Dis Colon Rectum, 2023, 66(7): 1012-1021.
[29]
Veereman G, Vlayen J, Robays J, et al. Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer:A real standard? [J]. Crit Rev Oncol Hematol, 2017, 114(1): 43-52.
[30]
Stijns RCH, de Graaf EJR, Punt CJA, et al. Long-term Oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer:the carts study [J]. JAMA Surg, 2019, 154(1): 47-54.
[31]
González JEB, Lavernia HC, Fraga JGP, et al. Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer [J]. Surg Endosc, 2022, 36(5): 2906-2913.
[32]
中华医学会消化内镜学分会消化内镜隧道技术协作组, 中国医师协会内镜医师分会, 北京医学会消化内镜学分会. 中国胃肠间质瘤内镜下诊治专家共识(2020,北京) [J]. 中华消化内镜杂志, 2021, 38(07): 505-514.
[33]
Yano T, Nakahara M, Okuda H, et al. Gastrointestinal stromal tumor of the rectum resected by transanal total mesorectal excision after neoadjuvant imatinib treatment: A case report[J]. Asian J Endosc Surg, 2020, 13(4): 574-577.
[34]
Bai X, Zhou W, Li Y, et al. Transanal endoscopic microsurgery with alternative neoadjuvant imatinib for localized rectal gastrointestinal stromal tumor: a single center experience with long-term surveillance [J]. Surg Endosc, 2021, 35(7): 3607-3617.
[35]
Kumar AS, Sidani SM, Kolli K, et al. Transanal endoscopic microsurgery for rectal carcinoids: the largest reported United States experience [J]. Colorectal Dis, 2012, 14(5): 562-566.
[36]
Brand M, Reimer S, Reibetanz J, et al. Endoscopic full thickness resection vs. transanal endoscopic microsurgery for local treatment of rectal neuroendocrine tumors - a retrospective analysis[J]. Int J Colorectal Dis, 2021, 36(5): 971-976.
[1] 高加勒, 张忠涛. 结直肠癌外科领域最新进展与热点[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 595-599.
[2] 杜晓辉, 谢天宇, 晏阳. 我国腹腔镜结直肠癌外科治疗现状、问题与未来[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 600-604.
[3] 陈朝乾, 赵宗贤, 徐顺, 姚远, 孙杰. 腹腔镜Dixon术中保留左结肠动脉对老年低位直肠癌患者的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 611-614.
[4] 严征远, 张恒, 曹能琦, 方兴超, 陈大敏. 单孔+1腹腔镜结直肠癌根治切除术的有效性及安全性临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 615-618.
[5] 周金哲, 王贤清, 李自强, 石启蒙, 张久强, 朱俩辰, 黄琦, 葛步军. 低位保肛新术式-结肠肛管套叠式吻合——附2例病例介绍[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 619-623.
[6] 王小军, 蔡瑜, 安艳新, 刘斌, 冯永安. 完全腹腔镜远端胃癌根治术治疗局部进展期胃癌的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 509-512.
[7] 贾宇浩, 吕坤昱, 刘志强, 李保中. 不同入路腹腔镜辅助下根治性远端胃切除术治疗进展期远端胃癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 513-516.
[8] 孔宪诚, 沙粒, 杜磊, 刘岗. 以卫式线引导的保留邓氏筋膜全直肠系膜切除术的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 523-526.
[9] 袁德玺, 徐海霞, 华秀丽, 申青. 适形保肛术对低位直肠癌患者术后肛门功能的影响研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 527-530.
[10] 杨敏, 辛林璞, 杜峻峰. 三精准管理方案对直肠癌造口术后造口并发症的预防效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 531-534.
[11] 吴少锋, 王茂, 马海龙, 史英, 代引海. 新辅助治疗后肿瘤退缩分级对局部进展期直肠癌患者全直肠系膜切除术效果的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 535-538.
[12] 肖燕玲, 杜升兰, 杨春梅, 许政文, 王玫. 正中切口在腹腔镜直肠癌根治术预防性回肠造口中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 539-542.
[13] 徐其银, 韩尚志. 术前结合术后营养支持对直肠癌患者康复的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 543-546.
[14] 邓吟咏, 钟洁, 蒋理立, 杨婕. 结直肠肿瘤手术后并发症的预测与预防:基于临床研究的最新进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 579-583.
[15] 杨春燕, 周晓苹. 机器人辅助技术在腹腔镜结直肠癌根治术中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 584-588.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?